Arcadia Biosciences, Inc. (RKDA) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Arcadia Biosciences, Inc. is a smaller reporting company focused on science-based agricultural and consumer goods. The company recently exited its GoodWheat and body care brands (classified as discontinued operations) and is currently pivoting to scale its Zola coconut water brand while monetizing its wheat trait portfolio. As of November 5, 2024, there were 1,364,940 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Total Revenue | $1.54 million | $1.30 million | $3.83 million | $3.68 million |
| Net Loss (Continuing Ops) | $(1.18) million | $(0.64) million | $(0.28) million | $(4.88) million |
| Net Loss (Total) | $(1.61) million | $(2.57) million | $(2.97) million | $(11.13) million |
| Net Loss Per Share (Diluted) | $(1.18) | $(1.89) | $(2.18) | $(9.31) |
| Cash & Equivalents | $3.94 million | $6.52 million (Dec 2023) | N/A | |
| Short-Term Investments | $2.64 million | $5.12 million (Dec 2023) | ||
| Working Capital | $8.38 million | $11.38 million (Dec 2023) | N/A | |
| Operating Cash Flow (YTD) | $(7.42) million | $(11.15) million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Product revenue increased 18% in Q3 2024 compared to Q3 2023, driven by higher sales of Zola coconut water. YTD revenue increased 4%.
- Asset Sales & Gains: The company recorded a $4.0 million gain on the sale of its non-GMO Resistant Starch (RS) durum wheat trait to Corteva AgriScience in May 2024. This significantly reduced the YTD net loss compared to the prior year.
- Discontinued Operations: The GoodWheat brand was sold in May 2024. Net loss from discontinued operations (GoodWheat and Body Care) was $0.43 million in Q3 2024, a significant improvement from $1.93 million in Q3 2023.
- Expense Increases: Selling, general, and administrative (SG&A) expenses increased 20% in Q3 2024, primarily due to employee severance costs related to management changes.
- Non-Cash Items: The prior year (Q3 2023) included a $6.1 million valuation loss related to the March 2023 PIPE financing, which was absent in the current period.
Outlook, Risks, and Management Commentary
- Going Concern Warning: Management has raised substantial doubt about the company's ability to continue as a going concern. With cash and short-term investments totaling approximately $6.6 million, the company believes these resources are insufficient to meet anticipated cash requirements for the next 12-18 months.
- Liquidity Strategy: The company may seek additional funds through debt or equity financings, which could result in dilution or restrictive covenants. If funding is not secured, the company may be forced to reduce spending, liquidate assets, or curtail product launches.
- Strategic Focus: Management plans to scale Zola through retail expansion and continue evaluating M&A opportunities. The company also retains rights to use the RS durum wheat trait sold to Corteva.
- Contingencies: A $2.0 million contingent liability remains on the balance sheet related to the 2005 Anawah acquisition, dependent on the commercial sale of specific products.
Key Investor Verification Points
- Cash Runway: Verify the sufficiency of the current $6.6 million in liquid assets against the stated 12-18 month burn rate and the timeline for potential new financing.
- Asset Sale Proceeds: Confirm the collection status of the $6.0 million promissory note received from Above Food for the GoodWheat sale (first installment due in 2025).
- Discontinued Operations: Ensure all liabilities related to the exited GoodWheat and Body Care brands have been fully settled or accounted for.
- Warrant Liabilities: Monitor the fair value adjustments of the liability-classified preferred investment options, which caused significant volatility in prior periods.
- Management Transition: Assess the impact of recent management changes and associated severance costs on future operational efficiency.